Sinan EROĞLU, İmran AYDOĞDU, Şule Nurdan YOLUÇ, Eren ŞAHİN, Yasemin EROĞLU

Chest Image Staging and Prevalence of Current Smoking Among Hospitalized COVID-19 Patients in Turkey

Objective: Novel coronavirus disease is a new infectious agent of the respiratory tract characterized by severe acute respiratory syndrome. For this disease, there are limited data with regard to the clinical characteristics of the patients and prognostic factors. Methods: We collected data from 213 patients who were hospitalized into COVID-19 isolation with positive PCR test results. We recorded various patient values, including blood test results. We also noted age, gender, additional diseases, duration of discharge, whether they live or die, whether they smoke, and their radiological staging. Results: In CT imaging with a staging of maximum 4 points and minimum 0 points, the mean value resulted in 1.95. The average radiological stage of the dead patients' group was reported as 2.56. There was a correlation between the radiological predictor and the outcome status (P = .002). The number of smokers was 14 (6.5%). Of the 26 patients who died, 3 were smokers and 23 were non-smokers. Conclusion: Fourteen patients in the study were smokers. While in COVID-19 isolation service, only a small rate of smoking was observed. That supports the theory that smoking has no negative impact on COVID-19 development. There was also a correlation between the radiological predictor and the outcome status. It seems that an elevated radiological stage is a predictor of death.

PDF

___

1. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689-697. [CrossRef]
2. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. [CrossRef]
3. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. [CrossRef]
4. Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020;295(1):202-207. [CrossRef]
5. Khot WY, Nadkar MY. The 2019 novel coronavirus outbreak: a global threat. J Assoc Physicians India. 2020;68(3):67-71.
6. Eapen MS, Sharma P, Moodley YP, Hansbro PM, Sohal SS. Dysfunctional immunity and microbial adhesion molecules in smokinginduced pneumonia. Am J Respir Crit Care Med. 2019;199(2):250-251. [CrossRef]
7. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 2020:2020.02.05.20020107. [CrossRef]
8. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-590. [CrossRef]
9. Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875-879. [CrossRef]
10. Li K, Fang Y, Li W, et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020;30(8) :4407-4416.[CrossRef]
11. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [CrossRef]
12. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8. [CrossRef]
13. Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614- 14621. [CrossRef]
14. Glowacka I, Bertram S, Herzog P, et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol. 2010;84(2):1198- 1205. [CrossRef]
15. Dijkman R, Jebbink MF, Deijs M, et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J Gen Virol. 2012;93(9):1924- 1929. [CrossRef]
16. Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020;81(5):537-540. [CrossRef]
17. Kostova D, Andes L, Erguder T, et al. Cigarette prices and smoking prevalence after a tobacco tax increase — Turkey, 2008 and 2012. MMWR Morb Mortal Wkly Rep. 2014;63(21):457-461.